A, M., R, N., RR, N., AJ, S., J, S., AM, S., & R, B. (2017). Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody. The Journal of neuroscience : the official journal of the Society for Neuroscience, 37(30), 7149. https://doi.org/10.1523/JNEUROSCI.0576-17.2017
Chicago Style (17th ed.) CitationA, Melo-Carrillo, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM, and Burstein R. "Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 37, no. 30 (2017): 7149. https://doi.org/10.1523/JNEUROSCI.0576-17.2017.
MLA (9th ed.) CitationA, Melo-Carrillo, et al. "Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol. 37, no. 30, 2017, p. 7149, https://doi.org/10.1523/JNEUROSCI.0576-17.2017.